Institute of Biomedical Engineering

The Institute of Biomedical Engineering at CAMS was founded in 1978, replacing its predecessor, the Institute of Medical Instrument Research, established in 1960. Research at the institute is primarily focused on developing new methods, technologies, and materials in the field of biomedical engineering.

The 129-member staff includes 91 research scientists and technical personnel. Areas of study fall into two major categories: biomedical materials and medical electronic engineering. Research on biomedical materials is conducted by the divisions of controlled-release drugs, tissue engineering and artificial organs, gene engineering, cardiovascular biomaterials, and molecular design and nanotechnology.

Medical electronic engineering is similarly divided into five divisions: medical ultrasound engineering, medical physics and measurement, neural engineering, bioinformatics, and medical lasers.
The Key Laboratory of Biomedical Materials and the Medical Electronic Diagnostic and Therapeutic Technology Engineering Center of Tianjin are also located within this institute, which also has an in-house editorial and publishing division that publishes the International Journal of Biomedical Engineering. 

The institute has garnered over 50 National and Provincial Science and Technology Awards over the years and has been particularly well-recognized for its contributions in the field of ultrasonic diagnosis and treatment—using high frequency ultrasound for imaging peripheral organs such as the eyes, skin, and micro vascular structures. The institute’s work with optical imaging in conjunction with focused ultrasound markedly improves the diagnosis of several types of glaucoma. Its BME-200 ophthalmic ultrasonic diagnostic instrument was awarded the second prize at the National Science and Technology Progress Awards in 2001.
Other medical and clinical equipment designed and developed at the institute include ultrasound instruments for ophthalmic and dermal examination, bedside monitors, an angelic stimulating device, a vision screening device, an antitumor photodynamic therapy system, photodynamic therapy system for port wine stain, a dual-wavelength medical laser apparatus, a pulse diagnosis system and moxibustion device intelligently controlled for use in traditional Chinese medicine, and a nasal drug delivery system. 
Research based on collagen, a natural compound with excellent biomaterial capability, has also been research focus of the institute, and has led tithe development of a variety of biomaterials for post-injury tissue regeneration. These collagen-guided regenerative biomaterials have won multiple national awards in basic and clinical research and have now been commercialized. They are in wide clinical use, particularly in orthopedic and stomatologic surgeries.

The development of nonmaterial, drug design and delivery systems, ultrasonic diagnosis and therapy, bioinformatics, medical lasers, and technology for traditional Chinese medicine has created a flood of medical data. In 2015, the institute established a healthcare management platform for data processing to facilitate the prevention of chronic disorders and contribute to the management of national healthcare.